All Pharma News
Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock

Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock
PR NEWSWIRE
26 Jun 2024
Share Share
Oramed Letter to Shareholders

Oramed Letter to Shareholders
PR NEWSWIRE
26 Jun 2024
Share Share
Oramed, HTIT Create Joint Venture to Advance Oral Drug Delivery

Oramed, HTIT Create Joint Venture to Advance Oral Drug Delivery
PR NEWSWIRE
02 Aug 2023
Share Share
Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit

Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit
PR NEWSWIRE
18 May 2023
Share Share
Oramed Announces that its Chinese Partner, HTIT, has Completed a Ph 3 Oral

Oramed Announces that its Chinese Partner, HTIT, has Completed a Ph 3 Oral
PR NEWSWIRE
15 May 2023
Share Share
Oramed to review strategic alternatives, clouding path forward for oral insulin

Oramed to review strategic alternatives, clouding path forward for oral insulin
Kyle LaHucik ENDPTS
10 Feb 2023
Share Share
Oramed Pharmaceuticals Issues Shareholder Update

Oramed Pharmaceuticals Issues Shareholder Update
PR NEWSWIRE
09 Feb 2023
Share Share
Oramed ditches oral insulin for diabetes after Phase III study failure

Oramed ditches oral insulin for diabetes after Phase III study failure
Nick Paul Taylor FIERCE BIOTECH
13 Jan 2023
Share Share
Oramed Granted U.S. Combination Therapy Patent for Oral GLP-1 and Insulin

Oramed Granted U.S. Combination Therapy Patent for Oral GLP-1 and Insulin
PR NEWSWIRE
04 Jan 2023
Share Share
Oramed Letter to Shareholders – December

Oramed Letter to Shareholders – December
PRESS RELEASE
21 Dec 2022
Share Share